Eli Lilly Dealt Another Setback as Lung Cancer Drug Flunks Phase III Test Post author:Sam Post published:October 9, 2017 Post category:BioPharma October 10, 2017By Alex Keown, BioSpace.com Breaking… Source: BioSpace You Might Also Like Valeant Plummets After Revealing Jaw-Dropping Payday for Its CEO April 4, 2017 Juno Therapeutics Spinout Raises $90M March 7, 2018 Insulet, Mayo Clinic Jump in On $35 Million Series C Funding Round June 27, 2017
